FDMT
Price
$11.34
Change
+$1.34 (+13.40%)
Updated
Oct 24 closing price
Capitalization
529.61M
10 days until earnings call
Intraday Buy/Sell Signals
RCUS
Price
$17.31
Change
+$0.53 (+3.16%)
Updated
Oct 24 closing price
Capitalization
1.84B
16 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

FDMT vs RCUS

Header iconFDMT vs RCUS Comparison
Open Charts FDMT vs RCUSBanner chart's image
4D Molecular Therapeutics
Price$11.34
Change+$1.34 (+13.40%)
Volume$2.32M
Capitalization529.61M
Arcus Biosciences
Price$17.31
Change+$0.53 (+3.16%)
Volume$539.71K
Capitalization1.84B
FDMT vs RCUS Comparison Chart in %
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. RCUS commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (FDMT: $11.34 vs. RCUS: $17.31)
Brand notoriety: FDMT and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 328% vs. RCUS: 54%
Market capitalization -- FDMT: $529.61M vs. RCUS: $1.84B
FDMT [@Biotechnology] is valued at $529.61M. RCUS’s [@Biotechnology] market capitalization is $1.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, RCUS is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 4 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • FDMT’s TA Score: 4 bullish, 4 bearish.
  • RCUS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, FDMT is a better buy in the short-term than RCUS.

Price Growth

FDMT (@Biotechnology) experienced а +15.24% price change this week, while RCUS (@Biotechnology) price change was +5.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Reported Earning Dates

FDMT is expected to report earnings on Nov 05, 2025.

RCUS is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($1.84B) has a higher market cap than FDMT($530M). FDMT YTD gains are higher at: 103.591 vs. RCUS (16.253). FDMT has higher annual earnings (EBITDA): -213.2M vs. RCUS (-282M). RCUS has more cash in the bank: 911M vs. FDMT (293M). FDMT has less debt than RCUS: FDMT (23.1M) vs RCUS (109M). RCUS has higher revenues than FDMT: RCUS (262M) vs FDMT (33K).
FDMTRCUSFDMT / RCUS
Capitalization530M1.84B29%
EBITDA-213.2M-282M76%
Gain YTD103.59116.253637%
P/E RatioN/AN/A-
Revenue33K262M0%
Total Cash293M911M32%
Total Debt23.1M109M21%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTRCUS
RSI
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 5 days ago
70%
N/A
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RCUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TWQIX17.080.15
+0.89%
Transamerica Large Cap Value I
OGFAX102.000.81
+0.80%
JPMorgan Equity Index R6
NBFAX37.130.29
+0.79%
Neuberger Berman Focus Adv
BOSYX20.120.12
+0.60%
BNY Mellon Sm Cp Val Y
ITETX10.110.03
+0.30%
VY® T. Rowe Price Equity Income S2

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+13.40%
RGNX - FDMT
45%
Loosely correlated
+3.58%
IMTX - FDMT
42%
Loosely correlated
N/A
CLDX - FDMT
41%
Loosely correlated
+1.75%
RCUS - FDMT
41%
Loosely correlated
+3.16%
IDYA - FDMT
41%
Loosely correlated
+2.67%
More

RCUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, RCUS has been loosely correlated with XNCR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RCUS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCUS
1D Price
Change %
RCUS100%
+3.16%
XNCR - RCUS
54%
Loosely correlated
+7.05%
IDYA - RCUS
49%
Loosely correlated
+2.67%
IMNM - RCUS
49%
Loosely correlated
-2.30%
APGE - RCUS
48%
Loosely correlated
-0.93%
IMTX - RCUS
47%
Loosely correlated
N/A
More